Electrospray ionization mass spectrometric analyses of changes in tissue phospholipid molecular species during the evolution of hyperlipidemia and hyperglycemia in Zucker diabetic fatty rats

Lipids

Volumn 35, Issue 8, 2000, Pages 839-852

  Hsu, F F ^a   Bohrer, A ^a   Wohltmann, M ^a   Ramanadham, S ^a   Ma, Z ^a   Yarasheski, K ^a   Turk, J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; GLYCEROPHOSPHOETHANOLAMINE; GLYCEROPHOSPHORYLCHOLINE; INSULIN; LIPID; PHOSPHOLIPID;

ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; BRAIN; CONTROLLED STUDY; ERYTHROCYTE; HEART; HYPERGLYCEMIA; HYPERLIPIDEMIA; INSULIN RELEASE; INSULIN RESISTANCE; ION CURRENT; KIDNEY; LIPID ANALYSIS; LIVER; MALE; MASS SPECTROMETRY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET; PROTEIN EXPRESSION; RAT; SCIATIC NERVE; SPECIES DIFFERENCE; TISSUE LEVEL;

ANIMALIA;

EID: 0033864847     PISSN: 00244201     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11745-000-0593-z     Document Type: Article

References (77)

1. Zucker diabetic fatty fat as a model for non-insulin-dependent diabetes mellitus
2. Alterations in pulsatile insulin secretion in the Zucker diabetic fatty rat
3. Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats. Impairment in adipocyte-beta-cell relationships
4. Evolution of β-cell dysfunction in the male Zucker diabetic fatty rat
5. Pancreatic beta cells in obesity. Evidence for induction of functional morphololgic and metabolic abnormalities by increased long-chain fatty acids
6. Leptin receptor missense mutation in the fatty Zucker rat
7. Substitution at codon 269 (glutamine to proline) of the leptin receptor cDNA is the only mutation found in the Zucker fatty (fa/fa) rat
8. Defective fatty acid-mediated beta-cell compensation in Zucker diabetic fatty rats. Pathogenic implications for obesity-dependent diabetes
9. Increased lipogenic capacity of the islets of obese rats. A role in the pathogenesis of NIDDM
10. Changes in pancreatic islet glucokinase and hexokinase activities with increasing age, obesity, and the onset of diabetes
11. Role of nitric oxide in obesity-induced beta-cell disease
12. Leptin or troglitazone-induced lipopenia protects islets from interleukin 1β cytotoxicity
13. Direct antidiabetic effect of leptin through triglyceride depletion of tissues
14. Induction by leptin of uncoupling protein-2 and enzymes of fatty acid oxidation
15. Role of apoptosis in failure of beta-cell mass compensation for insulin resistance and beta-cell defects in the male Zucker diabetic fatty rat
16. Enhanced de novo lipogenesis in the leptin-unresponsive pancreatic islets of prediabetic Zucker diabetic fatty rats. Role in the pathogenesis of lipotoxic diabetes
17. Troglitazone lowers islet fat and restores beta-cell function of Zucker diabetic fatty rats
18. Lipoapoptosis in beta cells of obese prediabetic fa/fa rats. Role of serine palmitoyltransferase over-expression
19. Fatty acid-induced beta-cell apoptosis: A link between obesity and diabetes
20. Role of peroxisome proliferator-activated receptor α in disease of pancreatic beta cells
21. Overexpression of leptin receptors in pancreatic islets of Zucker diabetic fatty rats restores GLUT-2, glucokinase, and glucose stimulated insulin secretion
22. Fatty acids, lipotoxicity, and insulin secretion
23. Leptin levels reflect body lipid content in mice. Evidence for diet-induced resistance to leptin action
24. Leptin
25. Beta cells in type II diabetes mellitus
26. Pathogenesis of NIDDM. A balanced overview
27. Phospholipid fatty acid remodeling in mammalian cells
28. Fatty acid incorporation into phospholipids of isolated pancreatic islets of the rat. Relationship to insulin release
29. Effects of starvation and different culture conditions on the phospholipid content of isolated pancreatic islets
30. Phosphatidylethanolamine N-methylation and insulin release in isolated pancreatic islets of the rat
31. Choline turnover in phosphatidylcholine of pancreatic islets. Implications for CDP-choline pathway
32. Mass spectrometric identification and quantitation of arachidonate containing phospholipids in pancreatic islets: Prominence of plasmenylethanolamine molecular species
33. Mass spectrometric characterization of arachidonate-containing plasmalogens in human pancreatic islets and in rat islet beta cells and subcellular membranes
34. Electrospray ionization mass spectrometric analyses of phospholipids from rat and human pancreatic islets and subcellular membranes. Comparison to other tissues and implications for membrane fusion in insulin exocytosis
35. The pancreatic islet as Rubik's cube. Is phospholipid hydrolysis a piece of the puzzle?
36. 2 by insulin secretagogues in isolated pancreatic islets
37. Diacylglycerol hydrolysis to arachidonic acid is necessary for insulin secretion from isolated pancreatic islets. Sequential actions of diacylglycerol and monoacylglycerol lipases
38. Unmasking of arachidonate induced insulin release by removal of extracellular calcium. Arachidonic acid mobilizes cellular calcium in islets of Langerhans
39. 2+ mobilization by arachidonic acid. Comparison with myo-inositol 1,4,5-triphosphate in isolated pancreatic islets
40. Free fatty acid accumulation in secretagogue stimulated pancreatic islets and effects of arachidonate on depolarization-induced insulin secretion
41. Arachidonic acid induces an increase in cytosolic calcium concentration in single pancreatic islet beta cells
42. Inhibition of arachidonate release by secretagogue-stimulated pancreatic islets suppresses both insulin secretion and the rise in beta-cell cytosolic calcium concentration
43. 2) in fatty acid incorporation, phospholipid remodeling, lysophosphatidylcholine generation, and secretagogue-induced arachidonic acid release in pancreatic islets and insulinoma cells
44. Plasmenylethanolamine facilitates rapid membrane fusion: A stopped flow kinetic investigation correlating the propensity of a major plasma membrane constituent to adopt an HII phase with its ability to promote fusion
45. Rapid plasmenylethanolamine-selective fusion of membrane bilayers catalyzed by an isoform of glyceraldehyde-3-phosphate dehydrogenase: Discrimination between glycolytic and fusogenic roles of individual isoforms
46. Reconstitution of membrane fusion between pancreatic islet secretory granules and plasma membranes. Catalysis by a protein constituent recognized by a monoclonal antibody directed against glyceraldehyde-3-phosphate dehydrogenase
47. Relationship between arachidonate-phospholipid remodeling and apoptosis
48. 2+ concentration
49. 2+ stores and arachidonic acid metabolism
50. 2 enzyme in clonal insulinoma cell lines
51. Electrospray ionization mass spectrometric analysis of INS-1 insulinoma cell phospholipids. Comparison to pancreatic islets and effects of fatty acid supplementation on phospholipid composition and insulin secretion
52. Arachidonic acid deficiency in streptozotocin induced diabetes
53. Electrospray ionization mass spectrometric analysis of human erythrocyte membrane phospholipids
54. Structural determination of picomole amounts of phospholipids via electrospray ionization tandem mass spectrometry
55. Formation of lithiated adducts of glycerophosphocholine lipids facilitates their identification by electrospray ionization tandem mass spectrometry
56. A subcellular fractionation approach for studying insulin release mechanisms and calcium metabolism in islets of langerhans
57. A rapid method of total lipid extraction and purification
58. Fast atom bombardment mass spectrometry of phospholipids
59. Tissue phospholipid fatty acid composition in the diabetic rat
60. Reduced arachidonic acid levels in major phospholipids of heart muscle in the diabetic rat
61. Plasma, platelet, and aorta fatty acids composition in response to dietary n-6 and n-3 fats supplementation in a rat model of non-insulin dependent diabetes
62. Altered fatty acid composition in the plasma, platelets, and aorta of the streptozotocin induced diabetic rat
63. Differential changes in relative levels of arachidonic acid in major phospholipids from rat tissues during progression of diabetes
64. Changes in microsomal membrane phospholipids and fatty acids and in activities of membrane-bound enzyme in diabetic rat heart
65. Reevaluation of the pathways for the biosynthesis of polyunsaturated fatty acids
66. Long chain fatty acid metabolism in fasting and diabetes. Relation between altered desaturase activity and fatty acid composition
67. Delta-6 and delta-5 desaturase activities in liver from obese Zucker rats at different ages
68. Changes in platelet phospholipids in diabetes mellitus
69. Increased arachidonic acid content in platelet phospholipids from diabetic patients
70. Increased arachidonic acid incorporation into platelet phospholipids in type 2 (non-insulin-dependent) diabetes
71. 2 generation in platelets from patients with diabetes mellitus
72. Increased susceptibility to lipid oxidation of low-density lipoproteins and erythrocyte membranes from diabetic patients
73. Maternal plasma phospholipid polyunsaturated fatty acids in pregnancy with and without gestational diabetes mellitus. Relations with maternal factors
74. Dietary fat and the diabetic state alter insulin binding and the fatty acyl composition of the adipocyte plasma membrane
75. Diet fat composition alters membrane phospholipid composition, insulin binding, and glucose metabolism in adipocytes from control and diabetic animals
76. The relation between insulin sensitivity and the fatty acid composition of skeletal muscle phospholipids
77. Skeletal muscle membrane lipid composition is related to adiposity and insulin action